Home
Conditions
Scleroderma, Systemic

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

433 public trials 124 recruiting studies

Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Not Yet Recruiting

Tissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs)

NCT07650565

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +4 more
Locations: University hospital Montpellier Montpellier, France

View Trial Details

Not Yet Recruiting

TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)

NCT07642297

Conditions: Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Fibrosis, +8 more
Locations: Immunorheumatology Unit, Fondazione Policlinico Universitario Campus Bio-Medico Rome, Italy

View Trial Details

Not Yet Recruiting

Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases

NCT07544225

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +18 more
Locations: Gustave Roussy Villejuif, Val de Marne, France

View Trial Details

Not Yet Recruiting

Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Systemic Sclerosis

NCT07535931

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis

NCT07502105

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Tongji Hospital, Tong ji Medical Colledge Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases

NCT07523282

Conditions: Autoimmune Disease, Autoimmune Diseases, Connective Tissue Diseases, +7 more
Locations: The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China

View Trial Details

Not Yet Recruiting

Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)

NCT07393217

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +17 more
Locations: Sohag University Hospital Sohag, Egypt

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma

NCT07326033

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations: Bordeaux Hospital Bordeaux, France

Dijon Hospital Dijon, France

Montpellier Hospital Montpellier, France

Nantes Hospital Nantes, France

View Trial Details

Not Yet Recruiting

Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases

NCT07301164

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, +29 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

NCT07212322

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +46 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Scleroderma, Systemic

Scleroderma, Systemic trial results

Related conditions